Health In TechvsVisa

HIT and V stock compared: price, dividend, valuation and results, from SEC filings.

Health In Tech (HIT) has a market value of $22M and Visa (V) $707B. Over the last year, with dividends, HIT moved -78.4% and V +26.6%. Dividend yield: HIT none, V 0.66%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HIT$22M

    V$707B

    V is 31,995 times HIT

  • Revenue, 12 months

    HIT$31M

    V$45.9B

    V is 1,484 times HIT

  • Net income, 12 months

    HIT-$11M

    V$23.5B

  • Operating margin

    HIT–

    V61.2%

  • ROIC

    HIT-67.4%

    V39.2%

    106.6 points apart

  • P/E

    HIT–

    V30.1

  • Dividend yield

    HIT0.0%

    V0.7%

    0.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HIT-78.4%

V+26.6%

50100DecFebAprJunAugOct
Returns by period
PeriodHITWith dividendsVWith dividends
1 year since November 12, 2025-78.4%Price -78.4%+26.6%Price +25.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HITHealth In TechVVisa

Valuation

HITV
Valuation
Price$0.40$425.76
Market value$22M$707B
Enterprise value (EV)$19M$715B
P/E–30.1
P/E, 5-year median––
P/B1.719.9
EV/EBIT–25.4
Free cash flow yield–3.1%

Results and growth

HITV
Results and growth
Revenue, 12 months$31M$45.9B
Net income, 12 months-$11M$23.5B
Free cash flow, 12 months–$22.1B
Earnings per share, 12 months-$0.19$14.16
Revenue growth, year on year71.0%14.8%
Revenue growth a year, past+31.9%over 2 years+13.8%over 5 years
EPS growth a year, past+100.0%over 1 years–

Margins and returns on capital

HITV
Margins and returns on capital
Gross margin50.5%–
Operating margin–61.2%
Net margin-37.1%51.2%
ROIC-67.4%39.2%
ROE-64.9%64.0%

Balance sheet

HITV
Balance sheet
Cash$10M$13.8B
Total debt$6.7M$23.0B
Net debt / EBITDA–0.3
Interest cover–37.1×

Dividends and buybacks

HITV
Dividends and buybacks
Dividend yield–0.7%
Dividend per share, 12 months–$2.79
Dividend growth a year, past––
Buyback yield–2.9%
Shareholder yield–3.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HIT or V

Didn't find what you were looking for?

Ask us
Which is bigger, Health In Tech or Visa?

By market value, Visa ($707B) is about 31,994.5 times Health In Tech ($22M), at today's prices.

How did HIT and V stock do over the last 1 years?

Since November 12, 2025, HIT's price moved -78.4% and V's +25.6%. With dividends: HIT -78.4% (-78.4% a year), V +26.6% (+26.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, HIT or V?

The dividend yield at today's price is none for Health In Tech and 0.66% for Visa. Over the last twelve months they paid – and $2.79 per share.

Which has the higher profit margins, Health In Tech or Visa?

Over the last twelve months, the net margin was -37.1% for Health In Tech and 51.2% for Visa, and the operating margin – and 61.2%. Revenue was $31M and $45.9B.

Which is the better investment, Health In Tech or Visa?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.